Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LVP plus radiotherapy for previously untreated early-stage NK/T-cell lymphoma
ChiCTR-TNC-09000394Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- May 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of asparaginase escherichia coli, vincristine and prednisone in natural killer/T-cell lymphoma (NKTL), sponsored by West China Hospital of Sichuan University. Primary endpoints: Response rate, Grade 3/4 toxicities and 1 more. Started May 2009; status: completed.
02
Drugs
asparaginase escherichia colivincristineprednisone
03
Conditions
natural killer/T-cell lymphoma (NKTL)
Beyond the preview
Go deeper on ChiCTR-TNC-09000394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-09000394.